Jane Street’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Sell
62,200
-900
-1% -$24.5K ﹤0.01% 5627
2026
Q2
$1.7M Sell
63,100
-51,000
-45% -$1.4M ﹤0.01% 5471
2026
Q1
$3.09M Buy
114,100
+17,700
+18% +$519K ﹤0.01% 4289
2025
Q4
$3.5M Buy
96,400
+65,800
+215% +$2.64M ﹤0.01% 3790
2025
Q3
$1.16M Buy
+30,600
New +$662K ﹤0.01% 5984
2025
Q2
– Sell
-67,100
Closed -$1.07M – 10407
2025
Q1
$1.07M Buy
+67,100
New +$772K ﹤0.01% 5452

Other funds holding MLYS

Jane Street's MLYS Position: Q3 2026 in Review

Jane Street opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 215,209 shares worth $5.41M. The stake represents ﹤0.01% of the portfolio and ranks #3620 among its holdings. This is a return to the name: Jane Street previously reported a position in MLYS as recently as Q3 2025.

Jane Street first reported a position in MLYS in Q3 2023 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Jane Street held 215,209 shares of Mineralys Therapeutics worth $5.41M as of Q3 2026.
  • Mineralys Therapeutics was a new Jane Street position in Q3 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #3620 holding.
  • Jane Street first reported a position in Mineralys Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.